My Companies
Notification
Account
Log Out
Login
Wanbury's Tanuku API facility received a USFDA Form 483 with six observations after a routine cGMP inspection. The company will respond within the stipulated time.
Wanbury Wins Rs15 Crore Mexico Tender Expands Saudi Metformin Business
Wanbury Secures Rivaroxaban EDQM Approval And Two USFDA DMF Clearances
Wanbury Board Approves Early Redemption of ₹180 Crore NCDs
Wanbury Trustee Releases 24.39% Pledge on Expert Chemicals Holding